A detailed history of Fox Run Management, L.L.C. transactions in Eli Lilly & CO stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 692 shares of LLY stock, worth $541,130. This represents 0.14% of its overall portfolio holdings.

Number of Shares
692
Holding current value
$541,130
% of portfolio
0.14%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $534,320 - $664,333
692 New
692 $613,000
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $474,953 - $557,809
1,529 New
1,529 $525,000
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $424,227 - $498,104
-1,522 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$234.69 - $291.66 $23,938 - $29,749
-102 Reduced 6.28%
1,522 $436,000
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $365,156 - $453,160
1,624 New
1,624 $449,000
Q2 2020

Jul 31, 2020

SELL
$136.42 - $164.18 $230,686 - $277,628
-1,691 Closed
0 $0
Q1 2020

May 08, 2020

BUY
$119.05 - $147.35 $201,313 - $249,168
1,691 New
1,691 $235,000
Q4 2018

Jan 15, 2019

SELL
$105.9 - $118.64 $691,103 - $774,244
-6,526 Closed
0 $0
Q3 2018

Oct 05, 2018

BUY
$85.86 - $107.31 $560,322 - $700,305
6,526 New
6,526 $700,000
Q2 2018

Jul 17, 2018

SELL
$75.7 - $86.88 $209,991 - $241,005
-2,774 Closed
0 $0
Q1 2018

Apr 17, 2018

SELL
$74.21 - $87.6 $25,528 - $30,134
-344 Reduced 11.03%
2,774 $215,000
Q4 2017

Jan 18, 2018

SELL
$81.94 - $87.89 $55,883 - $59,940
-682 Reduced 17.95%
3,118 $263,000
Q3 2017

Oct 23, 2017

BUY
$77.07 - $85.54 $292,866 - $325,052
3,800
3,800 $325,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $743B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.